NHS England reveals how it will widen access to Flash technology for type 1 diabetes on prescription
Posted on 07 March 2019
NHS England has today revealed how more people with type 1 diabetes will receive flash glucose monitoring on prescription – including more of those who were self-funding the technology themselves.
The move follows JDRF and partner charities speaking up on behalf of people with type 1 diabetes.
In November, NHS England announced patients across England will be able to receive the Freestyle Libre on prescription from their diabetes team, if they meet the clinical criteria. This criteria has been updated and has today been published on its website.
The criteria, which JDRF and partners including Diabetes UK and Input contributed to, now takes into account self-funders who currently pay for their own because they didn’t qualify for NHS provision. This was a key point the charities ensured was considered, after feedback from the type 1 diabetes community.
Whilst there are still limitations to access, the postcode lottery for Flash in England is now effectively ended. JDRF and Input, which merged in 2018, campaigned for over a year for wider access to Flash. The organisations will continue to push for wider UK access to this device and other type 1 diabetes technology.
Chief Executive Officer of JDRF in the UK, Karen Addington, said: “We are delighted that these new guidelines will effectively end the inequity of access to Flash Glucose Monitoring that people living with type 1 diabetes have experienced, based simply on where they live in England.
“JDRF has worked with NHS England and partners to secure this outcome and look forward to supporting the implementation in April.”
NHS commissioning bodies in Northern Ireland, Wales and most of Scotland have already agreed to provide the technology, although criteria affecting who receives it has varied.